Literature DB >> 8940271

High prevalence of a mutation in the cystathionine beta-synthase gene.

M Y Tsai1, M Bignell, K Schwichtenberg, N Q Hanson.   

Abstract

We found that a mutation previously described by Sebastio et al., involving a 68-bp insertion in the coding region of exon 8 of the cystathionine-beta-synthase (CBS) gene in a single patient with homocystinuria, is highly prevalent. In our control population, 11.7% (9/77) of the individuals were heterozygous carriers of this mutation. In contrast to the previous report, which assumed that the 68-bp insertion introduced a premature-termination codon and resulted in a nonfunctional CBS enzyme, we found that the presence of this mutation is not associated with hyperhomocysteinemia. Assay of CBS activity in transformed lymphocytes from individuals who were heterozygous or homozygous for this mutation showed normal activity. Furthermore, reverse-transcripion-PCR showed that individuals carrying this mutation have normal size mRNA. Our results suggest that the insertion creates an alternate splicing site, which eliminates not only the inserted intronic sequences but also the T833C mutation associated with this insertion. The net result is the generation of both quantitatively and qualitatively normal mRNA and CBS enzyme. Although the mutation does not seem to affect the activity of the CBS enzyme, the prevalence is somewhat increased in patients with premature coronary-artery disease, although the difference is not statistically significant.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8940271      PMCID: PMC1914870     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  17 in total

1.  A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians.

Authors:  M J Stampfer; M R Malinow; W C Willett; L M Newcomer; B Upson; D Ullmann; P V Tishler; C H Hennekens
Journal:  JAMA       Date:  1992-08-19       Impact factor: 56.272

2.  Simultaneous detection and screening of T833C and G919A mutations of the cystathionine beta-synthase gene by single-strand conformational polymorphism.

Authors:  M Y Tsai; N Q Hanson; M K Bignell; K A Schwichtenberg
Journal:  Clin Biochem       Date:  1996-10       Impact factor: 3.281

3.  Use of cyclosporin A in establishing Epstein-Barr virus-transformed human lymphoblastoid cell lines.

Authors:  M A Anderson; J F Gusella
Journal:  In Vitro       Date:  1984-11

4.  Hyperhomocysteinemia: an independent risk factor for vascular disease.

Authors:  R Clarke; L Daly; K Robinson; E Naughten; S Cahalane; B Fowler; I Graham
Journal:  N Engl J Med       Date:  1991-04-25       Impact factor: 91.245

Review 5.  Komrower Lecture. Molecular basis of phenotype expression in homocystinuria.

Authors:  J P Kraus
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

6.  Molecular basis of cystathionine beta-synthase deficiency in pyridoxine responsive and nonresponsive homocystinuria.

Authors:  F L Hu; Z Gu; V Kozich; J P Kraus; V Ramesh; V E Shih
Journal:  Hum Mol Genet       Date:  1993-11       Impact factor: 6.150

7.  A splicing enhancer in the human fibronectin alternate ED1 exon interacts with SR proteins and stimulates U2 snRNP binding.

Authors:  A Lavigueur; H La Branche; A R Kornblihtt; B Chabot
Journal:  Genes Dev       Date:  1993-12       Impact factor: 11.361

8.  The cardiac troponin T alternative exon contains a novel purine-rich positive splicing element.

Authors:  R Xu; J Teng; T A Cooper
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

9.  Nonsense codons can reduce the abundance of nuclear mRNA without affecting the abundance of pre-mRNA or the half-life of cytoplasmic mRNA.

Authors:  J Cheng; L E Maquat
Journal:  Mol Cell Biol       Date:  1993-03       Impact factor: 4.272

10.  Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis.

Authors:  J Selhub; P F Jacques; A G Bostom; R B D'Agostino; P W Wilson; A J Belanger; D H O'Leary; P A Wolf; E J Schaefer; I H Rosenberg
Journal:  N Engl J Med       Date:  1995-02-02       Impact factor: 91.245

View more
  27 in total

1.  A multilocus genotyping assay for candidate markers of cardiovascular disease risk.

Authors:  S Cheng; M A Grow; C Pallaud; W Klitz; H A Erlich; S Visvikis; J J Chen; C R Pullinger; M J Malloy; G Siest; J P Kane
Journal:  Genome Res       Date:  1999-10       Impact factor: 9.043

2.  Is the common 844ins68 polymorphism in the cystathionine beta-synthase gene associated with atherosclerosis?

Authors:  M Orendác; B Musková; E Richterová; J Zvárová; M Stefek; E Zaykova; J P Kraus; J Stríbrný; J Hyánek; V Kozich
Journal:  J Inherit Metab Dis       Date:  1999-06       Impact factor: 4.982

Review 3.  Vascular complications of cystathionine β-synthase deficiency: future directions for homocysteine-to-hydrogen sulfide research.

Authors:  Richard S Beard; Shawn E Bearden
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-10-22       Impact factor: 4.733

Review 4.  Homocysteine metabolism, hyperhomocysteinaemia and vascular disease: an overview.

Authors:  R Castro; I Rivera; H J Blom; C Jakobs; I Tavares de Almeida
Journal:  J Inherit Metab Dis       Date:  2006-02       Impact factor: 4.982

5.  Transcobalamin 2 variant associated with poststroke homocysteine modifies recurrent stroke risk.

Authors:  F-C Hsu; E G Sides; J C Mychaleckyj; B B Worrall; G A Elias; Y Liu; W-M Chen; B M Coull; J F Toole; S S Rich; K L Furie; M M Sale
Journal:  Neurology       Date:  2011-10-05       Impact factor: 9.910

6.  Hydrogen sulphide-related thiol metabolism and nutrigenetics in relation to hypertension in an elderly population.

Authors:  Mark Lucock; Zoë Yates; Charlotte Martin; Jeong-Hwa Choi; Lyndell Boyd; Sa Tang; Nenad Naumovski; Paul Roach; Martin Veysey
Journal:  Genes Nutr       Date:  2012-08-21       Impact factor: 5.523

7.  One-carbon metabolism and Alzheimer's disease: focus on epigenetics.

Authors:  Fabio Coppedè
Journal:  Curr Genomics       Date:  2010-06       Impact factor: 2.236

8.  Polygenic association with total homocysteine in the post-folic acid fortification era: the CARDIA study.

Authors:  Michael Y Tsai; Catherine M Loria; Jing Cao; Yongin Kim; David S Siscovick; Pamela J Schreiner; Naomi Q Hanson
Journal:  Mol Genet Metab       Date:  2009-06-06       Impact factor: 4.797

9.  Polymorphisms in methionine synthase (A2756G) and cystathionine beta-synthase (844ins68) and susceptibility to carcinomas of the upper gastrointestinal tract.

Authors:  N Ott; H Geddert; M Sarbia
Journal:  J Cancer Res Clin Oncol       Date:  2007-08-29       Impact factor: 4.553

10.  Hyperhomocysteinemia and cardiovascular disease: The nutritional perspectives.

Authors:  R Pandey; S Gupta; H Lal; H C Mehta; S K Aggarwal
Journal:  Indian J Clin Biochem       Date:  2000-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.